Neonatal Neurocritical Care Certification Examination Committee Contributors
Christopher D. Smyser, MD, Chair, Washington University SOM in St. Louis
Disclosures: Received research support from NIH. Serves as Secretary, Newborn Brain Society Board of Directors.
Alexa K. Craig, MD, MsC, MS, Vice Chair, Maine Medical Partners
Disclosures: Receives payment for participation in a data safety monitoring board with Eisai for a clinical trial. Receives research support from the Health Service Research Administration for a telehealth network development grant through her primary employer, MaineHealth.
Catherine J. Chu, MD, Johns Hopkins University
Disclosures: Received compensation for consulting with Novartis, Stoke Therapeutics, Ionis Pharmaceuticals, and Sensorium Therapeutics. Received research support from NINDS (3 R01-level grants), Epilepsy Foundation of New England, and Novartis (sponsored research award).
Dawn L. Gano, MD, MAS, University of British Columbia
Disclosures: Received research support from Cerebral Palsy Alliance Research Foundation - PI funding, California Preterm Birth Initiative - co-PI funding, NIH - co-Investigator Funding, California Institute for Regenerative Medicine - co-Investigator funding. Authored two neonatal encephalopathy chapters for UpToDate (no royalties collected). Served on the Editorial Board - Pediatric Neurology Associate Editor - Pediatric Research.
Terrie E. Inder, MD, Children’s Hospital of Orange County
Disclosures: Received compensation for serving as a consultant for Aspect Imaging and Chiesi Pharmaceutical. Received compensation for serving as an expert witness. Received research support from NIH. Participated on the American Board of Pediatrics Perinatal Neonatal Sub-board.
Sarah B. Mulkey, MD, PhD, Children’s National Hospital
Disclosures: Received compensation from Pfizer- Consultant for study on Lyme disease in pregnancy. Received compensation from Pediatric Research (Springer Nature)- Section Editor and Associate Editor, received small honorarium. Received research support from NIH- NICHD R01 grant for Zika research (PI) NIH- NICHD R01 grant for COVID neurodevelopmental outcomes research (Co-I).
Andrea C. Pardo, MD, Northwestern University Feinberg School of Medicine
Disclosures: Received compensation as Guest Editor- Elsevier- Clinics in Perinatology Section Editor (Neurology)- Wolters Kluwer- Current Opinion in Pediatrics. Has stock ownership- Allyx Inc, Celldom Inc, Saccharo Inc. Spouse received Research Support (R01) - role PI. Spouse received compensation as grant reviewer for NIH. Received compensation as grant reviewer from NUCATS Northwestern University. Chair of Professional Development Committee of the Child Neurology Society – creates questions for general neurologists seeking maintenance of certification activities through the SAEs.
Anna A. Penn, MD, PhD, Columbia University Dept. of Pediatrics
Disclosures: Receives compensation as employee of Columbia University Medical Center. Received research support from NIH Simons Foundation Autism Research Initiative (SFARI).
Mark S. Scher, MD, University Hospitals Case Medical Center
Disclosures: Nothing to disclose.
Emily Wing Yun Tam, MDCM, MAS, Hospital for Sick Children
Disclosures: Received compensation for serving as an expert witness for medicolegal cases via Carbert-Waite LLP. Received research project grants as principal investigator from the Canadian Institutes of Health Research (CIHR) and the National Institutes of Health (NIH). Received research funding support as site co-investigator of an industry-sponsored trial from UCB Biopharma SRL. Elected councillor for the Society for Pediatric Research. Co-chair of the committee for the Area of Focused Competency (AFC) working group in Neonatal Neurocritical Care (NNCC) at the Royal College of Physicians and Surgeons of Canada (RCPSC).
Charu Venkatesan, MD, PhD, Cincinnati Children’s Hospital
Disclosures: Received compensation as Invited Guest Editor: Seminars in Fetal Neonatal Medicine. Owns stock in Apple, Google, Amazon, Proctor and Gamble, and Tesla.
Michael D. Weiss, MD, UF Health Shands Children's Hospital
Disclosures: Received compensation for serving as a consultant for Belmont Medical, providing input on the design of the next-generation CritiCool device. My consulting contract concluded last year. Currently serving as consultant for Chiesi Pharmaceuticals, advising on the design of a clinical trial. Received compensation as a medical expert in multiple legal cases to assess and establish causation of brain injury in neonates with hypoxic-ischemic encephalopathy (HIE). Currently receives NIH funding through both an R01 grant and an SBIR grant focused on neonates with HIE. In addition, receives research funding from Realta for the STAR trial, which evaluates an adjunct therapy in combination with therapeutic hypothermia for neonates with HIE.